Recently Identified Colon Cancer Predispositions: MYH and MSH6 Mutations

Overview

Journal Semin Oncol

Specialty Oncology

Date 2007 Oct 9

PMID 17920897

Citations 11

Authors

Fay Kastrinos

Sapna Syngal

Affiliations

Soon will be listed here.

Abstract

Single-gene germline mutations conferring a high lifetime risk of colorectal cancer (CRC) account for up to 6% of all CRC cases. The most widely studied monogenic colorectal cancer syndromes include familial adenomatous polyposis (FAP) and Lynch syndrome. However, additional syndromes continue to be defined and new predisposition genes are continuing to be identified. Most recently, MYH-associated polyposis (MAP) and an "atypical Lynch syndrome" related to the presence of MSH6 mutations have been linked to an increased risk of CRC. In this review, we summarize basic information related to these newly recognized gene mutations, including the accumulating data on the prevalence and penetrance of deleterious mutations, as well as the management options for identified carriers and their families. Recognizing these heritable syndromes is essential and predictive genetic testing will continue to transform the field of cancer risk assessment by offering the opportunity to focus on more precise risk management and cancer prevention.

Citing Articles

Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers.

Guo T, Zhao S, Zhu W, Zhou H, Cheng H Heliyon. 2023; 9(11):e20653.

PMID: 38027682 PMC: 10643116. DOI: 10.1016/j.heliyon.2023.e20653.

PKMYT1: A Potential Target for CCNE1 Amplificated Colorectal Tumors.

Fang Y, Zhang X, Guo Y, Dong Y, Liu W, Hu X Cell Biochem Biophys. 2023; 81(3):569-576.

PMID: 37572218 DOI: 10.1007/s12013-023-01158-9.

Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective.

Chakraborty B, Agarwal S, Kori S, Das R, Kashaw V, Iyer A Curr Med Chem. 2023; 31(22):3286-3326.

PMID: 37151060 DOI: 10.2174/0929867330666230505165031.

Association between MSH6 G39E polymorphism and cancer susceptibility: a meta-analysis of 7,046 cases and 34,554 controls.

Li Z, Kong L, Yu L, Huang J, Wang K, Chen S Tumour Biol. 2014; 35(6):6029-37.

PMID: 24622885 DOI: 10.1007/s13277-014-1798-z.

Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study.

Plummer J, Chin S, Aronson M, Graham R, Williams N, Bapat B Can J Surg. 2012; 55(5):294-300.

PMID: 22854115 PMC: 3468640. DOI: 10.1503/cjs.037410.

References

Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington S . Association of MUTYH and colorectal cancer. Br J Cancer. 2006; 95(2):239-42. PMC: 2360610. DOI: 10.1038/sj.bjc.6603239. View

Croitoru M, Cleary S, Di Nicola N, Manno M, Selander T, Aronson M . Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004; 96(21):1631-4. DOI: 10.1093/jnci/djh288. View

Plaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E . Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol. 2004; 22(22):4486-94. DOI: 10.1200/JCO.2004.02.033. View

Rodriguez-Bigas M, Boland C, Hamilton S, Henson D, Jass J, Khan P . A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997; 89(23):1758-62. DOI: 10.1093/jnci/89.23.1758. View

Jones S, Emmerson P, Maynard J, Best J, Jordan S, Williams G . Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet. 2002; 11(23):2961-7. DOI: 10.1093/hmg/11.23.2961. View

Buttin B, Powell M, Mutch D, Babb S, Huettner P, Bocker Edmonston T . Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004; 74(6):1262-9. PMC: 1182090. DOI: 10.1086/421332. View

Nielsen M, Franken P, Reinards T, Weiss M, Wagner A, van der Klift H . Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005; 42(9):e54. PMC: 1736132. DOI: 10.1136/jmg.2005.033217. View

Wijnen J, De Leeuw W, Vasen H, van der Klift H, Moller P, Stormorken A . Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet. 1999; 23(2):142-4. DOI: 10.1038/13773. View

Sampson J, Dolwani S, Jones S, Eccles D, Ellis A, Evans D . Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003; 362(9377):39-41. DOI: 10.1016/S0140-6736(03)13805-6. View

10.

Peterlongo P, Mitra N, Chuai S, Kirchhoff T, Palmer C, Huang H . Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer. 2004; 114(3):505-7. DOI: 10.1002/ijc.20767. View

11.

Russell A, Zhang J, Luz J, Hutter P, Chappuis P, Berthod C . Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer. 2005; 118(8):1937-40. DOI: 10.1002/ijc.21470. View

12.

Boland C, Thibodeau S, Hamilton S, Sidransky D, Eshleman J, Burt R . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58(22):5248-57. View

13.

Lynch H, de la Chapelle A . Hereditary colorectal cancer. N Engl J Med. 2003; 348(10):919-32. DOI: 10.1056/NEJMra012242. View

14.

Nystrom-Lahti M, Wu Y, Moisio A, Hofstra R, Osinga J, Mecklin J . DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet. 1996; 5(6):763-9. DOI: 10.1093/hmg/5.6.763. View

15.

Fishel R . Signaling mismatch repair in cancer. Nat Med. 1999; 5(11):1239-41. DOI: 10.1038/15191. View

16.

Lindor N, Petersen G, Hadley D, Kinney A, Miesfeldt S, Lu K . Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006; 296(12):1507-17. DOI: 10.1001/jama.296.12.1507. View

17.

Sieber O, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips R . Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003; 348(9):791-9. DOI: 10.1056/NEJMoa025283. View

18.

Syngal S, Weeks J, Schrag D, Garber J, Kuntz K . Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998; 129(10):787-96. DOI: 10.7326/0003-4819-129-10-199811150-00007. View

19.

Vasen H, Mecklin J, Khan P, Lynch H . The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991; 34(5):424-5. DOI: 10.1007/BF02053699. View

20.

Petersen G, Slack J, Nakamura Y . Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology. 1991; 100(6):1658-64. DOI: 10.1016/0016-5085(91)90666-9. View